Avidity Biosciences’ HR Chief Triggers Routine Sell‑to‑Cover, Keeping Insider Confidence Steady Amid Coordinated Executive Liquidations
Investor insight: Avidity Biosciences’ execs, led by Teresa McCarthy, sell‑to‑cover RSUs in a routine, schedule‑driven pattern that signals confidence in long‑term prospects while keeping liquidity tight.
3 minutes to read